These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19188389)

  • 1. Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation.
    Suzuki H; Nishizawa T; Muraoka H; Hibi T
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1720-1. PubMed ID: 19188389
    [No Abstract]   [Full Text] [Related]  

  • 2. Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.
    Nishizawa T; Suzuki H; Kurabayashi K; Masaoka T; Muraoka H; Mori M; Iwasaki E; Kobayashi I; Hibi T
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1538-40. PubMed ID: 16569878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations.
    Murakami K; Okimoto T; Kodama M; Tanahashi J; Fujioka T; Ikeda F; Muraoka H; Takigawa M; Saika T; Hasegawa M; Kobayashi I
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3097-9. PubMed ID: 19380599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.
    Tankovic J; Lascols C; Sculo Q; Petit JC; Soussy CJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3942-4. PubMed ID: 14638505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR.
    Nishizawa T; Suzuki H; Umezawa A; Muraoka H; Iwasaki E; Masaoka T; Kobayashi I; Hibi T
    J Clin Microbiol; 2007 Feb; 45(2):303-5. PubMed ID: 17122023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.
    Rimbara E; Noguchi N; Kawai T; Sasatsu M
    Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective therapeutic regimens in two South Asian countries with high resistance to major
    Miftahussurur M; Aftab H; Shrestha PK; Sharma RP; Subsomwong P; Waskito LA; Doohan D; Fauzia KA; Yamaoka Y
    Antimicrob Resist Infect Control; 2019; 8():40. PubMed ID: 30815255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
    Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
    Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.
    Mori H; Suzuki H; Matsuzaki J; Tsugawa H; Fukuhara S; Miyoshi S; Hirata K; Seino T; Matsushita M; Masaoka T; Kanai T
    Helicobacter; 2016 Aug; 21(4):286-94. PubMed ID: 26612407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
    Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
    Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children.
    Fujimura S; Kato S; Iinuma K; Watanabe A
    J Med Microbiol; 2004 Oct; 53(Pt 10):1019-1022. PubMed ID: 15358825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.
    Hirata Y; Ohmae T; Yanai A; Sakitani K; Hayakawa Y; Yoshida S; Sugimoto T; Mitsuno Y; Akanuma M; Yamaji Y; Ogura K; Maeda S; Koike K
    Int J Antimicrob Agents; 2012 Apr; 39(4):352-5. PubMed ID: 22321702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on quinolone-containing rescue therapies for
    Mori H; Suzuki H
    World J Gastroenterol; 2020 Apr; 26(15):1733-1744. PubMed ID: 32351290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
    Chang WL; Kao CY; Wu CT; Huang AH; Wu JJ; Yang HB; Cheng HC; Sheu BS
    Helicobacter; 2012 Jun; 17(3):210-5. PubMed ID: 22515359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
    Chung JW; Lee GH; Jeong JY; Lee SM; Jung JH; Choi KD; Song HJ; Jung HY; Kim JH
    J Gastroenterol Hepatol; 2012 Mar; 27(3):493-7. PubMed ID: 21793912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
    Cheng AF; Yew WW; Chan EW; Chin ML; Hui MM; Chan RC
    Antimicrob Agents Chemother; 2004 Feb; 48(2):596-601. PubMed ID: 14742214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach.
    Glocker E; Kist M
    J Clin Microbiol; 2004 May; 42(5):2241-6. PubMed ID: 15131201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
    Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
    Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea.
    Lee JW; Kim N; Nam RH; Park JH; Kim JM; Jung HC; Song IS
    Helicobacter; 2011 Aug; 16(4):301-10. PubMed ID: 21762270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA.
    Trespalacios AA; Rimbara E; Otero W; Reddy R; Graham DY
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):251-5. PubMed ID: 25600075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.